Literature DB >> 9189125

Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.

C C Chen1, L E Holder, W A Scovill, A M Tehan, D S Gann.   

Abstract

UNLABELLED: The ability of 99mTc-pertechnetate/sestamibi subtraction, double-phase 99mTc-sestamibi and 99mTc-sestamibi SPECT imaging to localize abnormal parathyroid tissue was compared.
METHODS: Fifty-five consecutive patients had parathyroid imaging before surgery for hyperparathyroidism. Imaging consisted of 99mTc-pertechnetate pinhole images of the neck followed by 99mTc-sestamibi pinhole images of the neck and parallel-hole images of the neck and chest (early images). Within 2.5-4.0 hr later pinhole images of the neck, parallel-hole and SPECT images of the neck and chest were obtained (late images). Nodular foci of increased sestamibi activity were considered abnormal.
RESULTS: The sensitivity for abnormal parathyroid glands by visual comparison of early images and pertechnetate images was 72%-75%, late images and pertechnetate images was 73%-78% and double-phase (early and late) sestamibi images was 62%-65%; computer subtraction of pertechnetate from early images was 71%-74%; and SPECT imaging was 79%. The sensitivity for parathyroid adenomas was 89%-98%, while the sensitivity for hyperplastic parathyroid glands was only 47%-58%.
CONCLUSION: Late imaging, computer subtraction and SPECT may not be necessary since they provided only marginal improvements on visual comparison of early sestamibi with pertechnetate images. Double-phase sestamibi imaging was less sensitive, so baseline thyroid imaging with pertechnetate is recommended.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189125

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

1.  11C-methionine PET versus 99mTc-sestamibi in the pre-operative localisation of hyperfunctional parathyroid tissue.

Authors:  Theodoros Athanasoulis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

2.  The outcome of cervical exploration for asymptomatic and symptomatic patients with primary hyperparathyroidism.

Authors:  Jaber S Abbas; Suzan I Hashem; Walid G Faraj; Mohammad J Khalifeh; Mukbil H Horani; Ibrahim S Salti
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

3.  Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism.

Authors:  Tuan H Pham; Sylvester Sterioff; Brian P Mullan; Gregory A Wiseman; Thomas J Sebo; Clive S Grant
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

4.  A comparative study of pre-operative imaging methods in patients with primary hyperparathyroidism: ultrasonography, 99mTc sestamibi, single photon emission computed tomography, and magnetic resonance imaging.

Authors:  G Akbaba; D Berker; S Isik; Y Aydin; D Ciliz; I Peksoy; U Ozuguz; Y A Tutuncu; S Guler
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

Review 5.  Imaging techniques in parathyroid surgery for primary hyperparathyroidism.

Authors:  Arash Mohebati; Ashok R Shaha
Journal:  Am J Otolaryngol       Date:  2011-12-07       Impact factor: 1.808

6.  Sensitive Detection of a Small Parathyroid Adenoma Using Fluorocholine PET/CT: A Case Report.

Authors:  Thanseer N T K Padinhare-Keloth; Sanjay K Bhadada; Ashwani Sood; Rajender Kumar; Arunanshu Behera; Bishan D Radotra; Bhagwant R Mittal
Journal:  Nucl Med Mol Imaging       Date:  2016-09-20

7.  Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and 123I for localization of rapid washout parathyroid adenomas.

Authors:  Y S Kushchayeva; S H Tella; S V Kushchayev; D Van Nostrand; K Kulkarni
Journal:  Osteoporos Int       Date:  2019-01-31       Impact factor: 4.507

8.  Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.

Authors:  M Kebapci; E Entok; N Kebapci; B Adapinar
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

9.  Value of 123I-subtraction and single-photon emission computed tomography in addition to planar 99mTc-MIBI scintigraphy before parathyroid surgery.

Authors:  Francisca H Jorna; Pieter L Jager; Tjin H Que; Clara Lemstra; John T M Plukker
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

Review 10.  Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature.

Authors:  Martin Gotthardt; Bodo Lohmann; Thomas M Behr; Artur Bauhofer; Christiane Franzius; Meike L Schipper; Maria Wagner; Helmut Höffken; Helmut Sitter; Matthias Rothmund; Klaus Joseph; Christoph Nies
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.